Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Sex Differences in Diabetes Mellitus Mortality Trends in Brazil, 1980-2012

Sex Differences in Diabetes Mellitus Mortality Trends in Brazil, 1980-2012

  • Thainá Alves Malhão, 
  • Alexandre dos Santos Brito, 
  • Rejane Sobrino Pinheiro, 
  • Cristiane da Silva Cabral, 
  • Thais Medina Coeli Rochel de Camargo, 
  • Claudia Medina Coeli
PLOS
x

Abstract

Aims

To investigate the hypothesis that the change from the female predominance of diabetes mellitus to a standard of equality or even male preponderance can already be observed in Brazilian mortality statistics.

Methods

Data on deaths for which diabetes mellitus was listed as the underlying cause were obtained from the Brazilian Mortality Information System for the years 1980 to 2012. The mortality data were also analyzed according to the multiple causes of death approach from 2001 to 2012. The population data came from the Brazilian Institute of Geography and Statistics. The mortality rates were standardized to the world population. We used a log-linear joinpoint regression to evaluate trends in age-standardized mortality rates (ASMR).

Results

From 1980 to 2012, we found a marked increment in the diabetes ASMR among Brazilian men and a less sharp increase in the rate among women, with the latter period (2003–2012) showing a slight decrease among women, though it was not statistically significant.

Conclusions

The results of this study suggest that diabetes mellitus in Brazil has changed from a pattern of higher mortality among women compared to men to equality or even male predominance.

Introduction

The prevalence of diabetes mellitus has increased considerably in the last decades and varies between communities, showing differences in environmental and genetic factors [1]. Global estimates indicate that the total number of adults aged 20–79 years with this illness will rise from 415 million in 2015 to 642 million in 2040. Likewise, prevalence will increase from 8.8% to 10.4% in the same period [1].

Some studies have found sex differences in risk factors, clinical manifestations and sequelae of diabetes mellitus and verified that prevention, detection, and treatment affect men and women differently [23]. Moreover, data had shown that this disease went from a pattern of higher prevalence among women compared to men to equality or even male predominance [46].

In Brazil, despite the increase in prevalence [79], this change between sexes is not clear. We observed different results between studies that assessed diabetes status through self-report questionnaires and surveys based on blood glucose measurement. Between 1986 and 1988, the only multicenter survey of national scope that was carried out, which included blood glucose screening, found that men and women had similar prevalence rates of diabetes [10]. Local studies based on blood tests also showed that differences in diabetes prevalence in the male and female populations disappear when pre-diagnosed and undiagnosed cases are evaluated [11]. However, an investigation conducted between 2010 and 2012, which included blood glucose measurement, concluded that diabetes affects more men than women [12]. On the other hand, national surveys based on the self-reported prevalence of diabetes mellitus were always higher for women than men [78, 13].

Mortality statistics could shed some light on the sex difference in diabetes prevalence. In Brazil, the majority of deaths occurs in hospitals [14], increasing the odds of diagnosing and reporting diabetes in the death certificate. The mortality data are thus less influenced by late diagnosis when compared to self-reported studies, still relatively frequent in this country [15]. Therefore, the aim of this study was to evaluate the pattern of mortality from diabetes mellitus by sex, from 1980 to 2012, in order to assess whether a change from female diabetes mortality predominance to a standard of equality or even male preponderance has occurred in Brazil.

Materials and Methods

We carried out an ecological, time-series study based on official Brazilian statistics. For the calculation of diabetes mortality rates, we used the Brazilian Mortality Information System (from 1980 to 2012; available at http://www.datasus.gov.br) and population data provided by the Brazilian Institute of Geography and Statistics (IBGE, available at http://ibge.gov.br/home/). We used data from National Censuses (1980, 1991, 2000 and 2010), Population Count (1996) and estimates (for the remaining years).

We used two different approaches in order to calculate diabetes mortality rates. From 1980 to 2012, we included the death records that mention diabetes mellitus as the underlying cause. For the 2001–2012 period, we also included records in which diabetes mellitus was mentioned as an associated cause of death, either in Part I or in Part II of the cause-of-death section of the death certificate. Associated causes of death became available in the Brazilian mortality databases in 1999. However, within the initial period (1999 to 2000), the completeness of this information was low. For record selection, we used the International Classification of Diseases (ICD) codes corresponding to diabetes mellitus, as follows: 250 of the ninth revision (1980–1995); and E10 to E14 of the tenth revision (1996–2012).

We calculated both crude and age-adjusted mortality rates according to sex. We calculated the annual age-adjusted mortality rates (ASMR), with 95% confidence intervals and used the direct method [16], standardized to the world population in 2012 [17]. We considered the following groups: 20–29, 30–39, 40–49, 50–59, 60–69, 70–79 and 80 or more years old.

We applied the log-linear joinpoint regression to evaluate trends in age-standardized mortality rates and its annual percentage change (APC), with a 95% confidence interval. The joinpoint regression model considered the heteroscedasticity and autocorrelation of the random errors.

The maximum number of joinpoints was determined based on the number of data points, according to the grid search method. The final model considered the number of joinpoints statistically significant at an overall level of significance of 5% [18]. The Average Annual Percentage Change (AAPC) was also calculated to compare the estimated changes in mortality. A positive and negative AAPC indicated an increase and decrease in the mean trend, respectively [19].

ASMR and their standard errors were computed using STATA version 10.1 (Stata Corp., College Stata Station, TX; www.stata.com). Moreover, the joinpoint regression was carried out using the Joinpoint Software version 4.1.1 available from the National Cancer Institute (NCI; http://surveillance.cancer.gov/joinpoint/).

The patient records/information were anonymized and de-identified before analysis. Thus, there is no identification of individuals from our aggregate data. Moreover, the data are public and available on government websites.

The ethics committee from the Institutional Review Board of the Institute for Studies in Collective Health (IESC) at the Federal University of Rio de Janeiro (UFRJ) approved this study (CAE 48174515.0.0000.5286).

Results

Underlying cause of death

From 1980 to 2012, 955,455 people in Brazil aged 20 years or older died of diabetes mellitus. Women accounted for 57.7% (n = 551,016) of deaths and men, 42.3% (n = 404,439).

The ASMR from diabetes mellitus has increased since 1980, from 20.8 per 100,000 (95% CI: 20.2–21.5) to 47.6 per 100,000 (95% CI: 47.0–48.2) for men and from 28.7 per 100,000 (95% CI: 27.9–29.4) to 47.2 per 100,000 (95% CI: 46.7–47.7) for women in 2012 (Table 1).

thumbnail
Table 1. Deaths mentioned as the underlying cause and mortality rates from diabetes mellitus by sex. Brazil, 1980 to 2012.

https://doi.org/10.1371/journal.pone.0155996.t001

Fig 1 shows joinpoint analysis for diabetes mellitus mortality rates by sex in Brazil, from 1980 to 2012, according to the underlying cause of death. Overall, there was an increase in the death rate trend in both sexes. However, among men and women, this trend has changed according to particular periods.

thumbnail
Fig 1. Joinpoint analysis for diabetes mellitus mortality rates (deaths mentioned as the underlying cause) by sex. Brazil, 1980 to 2012.

*Age-standardized rate per 100,000 (using world population in 2012) ^ The Annual Percent Change (APC) is significantly different from zero at level of significance = 0.05.

https://doi.org/10.1371/journal.pone.0155996.g001

In men, between the years 1980 to 2005 and 2005 to 2012, mortality rates rose 3.4% (APC = 3.4 and 95% CI: 3.2, 3.7) and 0.9% per year (APC = 0.9, 95% CI: -0.1, 1.9), respectively. (Table 2). In women, between the years 1980 to 2003, mortality rates grew 2.4% (APC = 2.4 and 95% CI: 2.2, 2.6) per year. Nevertheless, between 2003 and 2012, there was a reduction of 0.1% per year (APC = -0.1, 95% CI: -0.7, 0.5), but it was not statistically significant (Table 2). Considering the entire analyzed period (1980–2012), the rate increased 2.9% per year in men (AAPC = 2.9, 95% CI: 2.6, 3.1) and 1.7% in women (AAPC = 1.7, 95% CI: 1.5, 1.9) (Table 2).

thumbnail
Table 2. Joinpoint analysis for diabetes mellitus mortality rates (deaths mentioned as the underlying cause) by sex. Brazil, 1980 to 2012.

https://doi.org/10.1371/journal.pone.0155996.t002

Multiple causes of deaths

Considering diabetes mellitus as the underlying or associated cause of mortality from 2001 to 2012, the number of deaths was 1,076,434 (women: 603,686–56.1%; men: 472,748–43.9%). This represents a 95.2% increase when compared with the figures based only on the underlying cause of death in the same period.

The ASMR from diabetes mellitus has increased since 2001, from 76.1 per 100,000 (95% CI: 75.2–77.0) to 95.6 per 100,000 (95% CI: 94.8–96.5) for men and from 83.7 per 100,000 (95% CI: 82.9–84.6) to 93.3 per 100,000 (95% CI: 92.6–94.1) for women in 2012 (Table 3).

thumbnail
Table 3. Deaths and mortality rates from diabetes mellitus (multiple causes of death approach) by sex. Brazil, 2001 to 2012.

https://doi.org/10.1371/journal.pone.0155996.t003

According to the joinpoint analysis (Fig 2, Table 4), in men, from the years 2001 to 2005 and 2008 to 2012, mortality rates from diabetes increased 5.2% (APC = 5.2 and 95% CI: 3.6, 6.8) and 2.8% per year (APC = 2.8, 95% CI: 1.6, 4.1), respectively. Nevertheless, between 2005 and 2008, there was a decline of 1.9% per annum (APC = -1.9 and 95% CI: -7.6, 4.2) (Table 4).

thumbnail
Fig 2. Joinpoint analysis for diabetes mellitus mortality rates (multiple causes of death approach) by sex. Brazil, 2001 to 2012.

*Age-standardized rate per 100,000 (using world population in 2012) ^ The Annual Percent Change (APC) is significantly different from zero at level of significance = 0.05.

https://doi.org/10.1371/journal.pone.0155996.g002

thumbnail
Table 4. Joinpoint analysis for diabetes mellitus mortality rates (multiple causes of death approach) by sex. Brazil, 2001 to 2012.

https://doi.org/10.1371/journal.pone.0155996.t004

In women, mortality rates have risen 3.7% (APC = 3.7 and 95% CI: 3.0, 4.3) and 1.4% per year (APC = 1.4, 95% CI: 0.9, 2.0), from 2001 to 2005 and 2008 to 2012, respectively. Nonetheless, between 2005 and 2008, there was a decrease of 2.9% per year (APC = -2.9, 95% CI: -5.4, -0.3) (Table 4).

Between 2001 and 2012, the ASMR grew 2.4% per year (AAPC = 2.4, 95% CI: 1.1, 3.7) in men and 1.0% in women (AAPC = 1.0, 95% CI: 0.5, 1.6) (Table 4).

Discussion

In Brazil, from 1980 to 2012, we found a marked increment in the diabetes ASMR among men and a less sharp increase in the rate among women, with the latter period (2003–2012) showing a slight decrease among women, though it was not statistically significant. This indicates a change in the sex ratio. Diabetes mellitus is frequently under-reported in mortality statistics, especially when based only on the underlying cause of death [2021]. This study corroborates these findings. In the analysis that considered any mention of diabetes in the death certificate, we identified that in half of the cases, diabetes was reported as the underlying cause of death. Nevertheless, we observed a rising trend of ASMR from diabetes mellitus in both sexes, regardless of the approach used. This trend is a result of the interplay between the increment in diabetes incidence and prevalence, as well as in the risk of death among people with diabetes.

In Brazil, from 1986 to 1987, the self-reported prevalence of diabetes mellitus was 4.1% among the urban population aged 30–69 years (men: 3.1%; women: 4.7%) [10]. In 2013, this value was 6.2% (men: 5.4%; women: 7.0%) among individuals aged 18 years or older [13]. Considering the estimates from the World Health Organization, the national prevalence of raised blood glucose among Brazilian adults (18 + years old) increased from 7.0% (men: 7.1%; women: 6.8%) in 2010, to 7.6% (men: 8.0%; women: 7.3%) in 2014 [22].

As in other countries, the growing prevalence resulted from population aging, a rapid increase in overweight/obesity and a rise in unhealthy lifestyles [23]. The expanded access to diagnosis and treatment, resulting from a series of population health interventions implemented during the last decades, may also play a significant role. First, the creation of the Unified Health System (SUS), in 1988, based on the universal right to health care, and which, in theory, assures unrestricted access to the entire population [24]. Second, the expansion of the Family Health Strategy, which implements a model of primary care in which families living within a specific geographical area receive preventive and curative health interventions that are carried out by a multiprofessional team [25]. Finally, the implementation of health policies that seek specifically to control non-communicable diseases, such as the Brazilian Ministry of Health’s Plan for the Reorganization of Care for Arterial Hypertension and Diabetes Mellitus [26], created in 2001, and the Strategic Action Plan for Confronting Chronic Non-communicable Diseases in Brazil 2011–2022, launched in 2011 [15, 27].

This pattern of growth in mortality rates did not follow, in general, the evidence found in epidemiological studies conducted in different countries. The increasing incidence and prevalence notwithstanding, these investigations found a reduction in mortality from diabetes mellitus in recent decades [5, 2829]. The possible explanations given this decline were: (a) decrease in mortality from coronary heart disease and stroke; (b) lower exposure to risk factors (e.g. smoking); (c) active search and screening for early detection and; (d) development of medical interventions for the reduction of blood glucose, blood cholesterol, and arterial pressure [2930]. In Brazil, these trends are also in place, but are much more recent [23]. It is to be expected that their impact will take some time to become evident. Nonetheless, our results seem to suggest effects are already under way, especially among women, for whom the ASMR for diabetes has stabilized.

The change in the sex ratio observed in our results is consistent with recent data that shows that, in developed countries, this disease has shifted from a pattern of higher prevalence among women compared to men to equality or even male predominance [46]. Likewise, it supports the results found in a Brazilian investigation, which included blood glucose measurement and verified that diabetes affects more men than women [12].

Though the reasons for the change in the sex ratio remain unclear, sex-dissimilarities in biology and the different ways that men and women respond to broad contextual changes in recent years in Brazil can help us to interpret our results.

Men develop type 2 diabetes at a lower body-mass index (BMI) than women [31]. Moreover, they have higher waist circumference, greater amounts of visceral and hepatic fat and are more insulin resistant [3133]. For that reason, the rise in diabetes mortality among Brazilian men could be associated with the higher growth in the proportion of overweight (BMI ≥ 25 Kg/m²) individuals among this group when compared with women between the periods 1974–1985 (men: 18.5%; women: 28.7%) and 2008–2009 (men: 50.1%; women: 48.0%) [34].

Additionally, women with diabetes have a greater excess risk for fatal coronary heart disease than men [3537]. This is because women have a higher number of vascular risk factors, such as inflammatory parameters, unfavorable changes in coagulation and blood pressure, especially after menopause [35]. They also have worse results in their treatment, probably due to sex differences in the effects of drug therapy [35]. Thus, the reduction in the growth of ASMR among women could be a reflex of the decrease in cardiovascular mortality verified in Brazil in the last decade [23].

Thus far, in this article, we have examined the change in the sex ratio and its possible explanations in terms of sex. This is because the information recorded on death certificates, from which we have extracted the data for this analysis, refers to male and female sex, and not to gender. However, as the vast majority of the population is cisgender, we can consider that these groups reflect, overall, men and women. This fact enables us to consider gender disparities as possible explanations for the differences in prevalence and mortality we are discussing.

Though access to education had expanded for all Brazilians in this period, women had greater gains than men in terms of educational attainment [38]. Several studies have shown that educational attainment is inversely associated with diabetes [3942]. Additionally, this association is also more pronounced among women than among men [3940, 42]. A possible mechanism at play is that increases in schooling have a causal effect on maintaining a healthy BMI and waist circumference among women more so than among men [43]. This would result, for example, in the greater proportion of overweight individuals among men [4445].

We also expect policies that expand access to care to benefit men less than women. Women utilize health care services more frequently, at least in part due to pregnancy, childbirth and a larger number of chronic conditions [11, 37]. Another possible explanation is that men value health less than women and are less likely to believe that health care is effective [11]. Therefore, it is possible that Brazilian men are accessing diagnosis at a later stage, after the onset of complications from diabetes, and when the prognosis is worse [11]. The inclusion of a gender perspective in health planning is, therefore, necessary in order to improve health care service use, especially among men, and in order to guarantee the success of the opportunistic screening strategy proposed by the American Diabetes Association [46].

Investigations using mortality statistics, such as ours, involve the analysis of data available on death certificates in large populations. As a result, when combined with other types of studies, they allow us to understand better the sex differences in diabetes mellitus in Brazil. This study could contribute to developing public programs and policies to improve diagnosis and management of diabetes based on gender differences. The cost-efficiency advantage given by this type of study makes it proper for examining scientific hypotheses that can be further tested adopting more robust research designs [22]. It is also true that their results should be considered in light of several limitations, as available below. In Brazil, the coverage and the quality of the Mortality Information System improved during the period studied, which may overestimate the increase in mortality rates [47]. The completeness of death counts rose from about 80% in 1980–1991 to over 95% in 2000. At the same time, the proportion of ill-defined causes of deaths decreased by about 53% [47]. Besides, there is potential for misclassification of diabetes type in the Brazilian Mortality Information System. As a result, approximately 90% of deaths from diabetes mellitus are unspecified, hampering the comparison between type 1 or type 2 diabetes [14]. Likewise, the growth in mortality can also be partly an effect of the modifications in the diagnostic criteria [48]. An additional limitation that should be considered is the change in the classification system for coding the cause of death. However, previous studies of comparability between ICD-9 and ICD-10 observed small differences in definitions of coding methods, which did not generate distortions in the quantity of deaths from diabetes mellitus [49].

One strength of the present study is the availability of data for a longer period. Although previous studies carried out in Brazil showed a growing trend of the mortality rate for diabetes [15], to our knowledge, this was the first study that demonstrated the changes in the sex ratio mortality for diabetes according to different periods of time. The joinpoint regression analysis allows us to determine changes in the trends of mortality rates and to recognize exactly when these changes occur and measure them [50]. Another benefit is that there is no need to pre-specify periods, avoiding bias in the investigation. For instance, in our study the years of 2005 for men and 2003 for women were identified as the joinpoints. The disadvantage is the fact that the associated time intervals could be different for each population subgroup, hampering the comparison among them [51].

Conclusions

In conclusion, diabetes mellitus mortality rates are increasing among Brazilian men and possibly decreasing among women. The results of this study therefore indicate that this disease has changes from a pattern of higher mortality among women compared to men to equality or even male predominance. However, further investigation must be conducted to elucidate these patterns and the sex differences in diabetes outcomes.

Author Contributions

Conceived and designed the experiments: CMC TAM ASB. Performed the experiments: TAM ASB. Analyzed the data: TAM ASB RSP CSC TMCRC CMC. Wrote the paper: TAM ASB RSP CSC TMCRC CMC.

References

  1. 1. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels: International Diabetes Federation; 2015. 144 p.
  2. 2. Grant JF, Hicks N, Taylor AW, Chittleborough CR, Philips PJ; North West Adelaide Health Study Team. Gender-specific epidemiology of diabetes: a representative cross-sectional study. Int J Equity Health. 2009;8:6. pmid:19284598
  3. 3. Cunningham-Myrie C, Younger-Coleman N, Tulloch-Reid M, McFarlane S, Francis D, Wilks R, et al. Diabetes mellitus in Jamaica: sex differences in burden, risk factors, awareness, treatment and control in a developing country. Trop Med Int Health. 2013;18(11):1365–78. pmid:24128301
  4. 4. Gale EAM, Gillespie KM. Diabetes and gender. Diabetologia. 2001;44(1):3–15. pmid:11206408
  5. 5. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet. 2007;369(9563):750–6. pmid:17336651
  6. 6. Chang HY, Hsu CC, Pan WH, Liu WL, Cheng JYC, Hurng BS, et al. Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res Clin Pract. 2010;90(3):358–64. pmid:20970872
  7. 7. Freitas LRS, Garcia LP. [Evolution of prevalence of diabetes and associated hypertension in Brazil: analysis of National Household Sample Survey, 1998, 2003 and 2008] Epidemiol Serv Saude. 2012;21(1):7–19. Portuguese.
  8. 8. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. Vigitel Brasil 2013: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde; 2014. 164 p. Portuguese.
  9. 9. Aschner P, Aguilar-Salinas C, Aguirre L, Franco L, Gagliardino JJ, Vinocour M, et al. IDF Diabetes Atlas: Diabetes in South and Central America: an update. Diabetes Res Clin Pract. 2014;103(1):238–43.
  10. 10. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30–69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care. 1992;15(11):1509–16. pmid:1468278
  11. 11. Coeli CM, Faerstein E, Chor D, Lopes CS, Werneck GL. Gender differences in the socioeconomic gradient in self-reported diabetes: Does health service access play a role? Diabetes Res Clin Pract. 2009;86(2):134–9. pmid:19748148
  12. 12. Schmidt MI, Hoffmann JF, Diniz MFS, Lotufo PA, Griep RH, Duncan BB, et al. High prevalence of diabetes and intermediate hyperglycemia—The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr. 2014;6:123. pmid:25788987
  13. 13. Instituto Brasileiro de Geografia e Estatística. Diretoria de Pesquisas. Coordenação de Trabalho e Rendimento. Pesquisa Nacional de Saúde 2013. Percepção do estado de saúde, estilos de vida e doenças crônicas. Brasil, grandes regiões e unidades da federação. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2014. 180 p. Portuguese.
  14. 14. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Coordenação Geral de Informações e Análise Epidemiológica. Departamento de Análise de Situação de Saúde. Mortalidade Geral [Internet]. Brasília: Ministério da Saúde; 2014 –[cited 2014 Aug 24]. Available from: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/obt10uf.def.
  15. 15. Almeida-Pititto B, Dias ML, Moraes ACF, Ferreira SRG, Franco DR, Eliaschewitz FG. Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab Syndr Obes. 2015;8:17–28. pmid:25609989
  16. 16. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes. 2001;20:1–10. pmid:11676466
  17. 17. United States of America Department of Commerce. U.S. Census Bureau. International Database [Internet]. Washington, DC: United States of America Department of Commerce; 2012—[cited 2014 Aug 24]. Available: http://www.census.gov/population/international/data/idb/worldpop.php.
  18. 18. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351. Erratum in: Stat Med. 2001;20(4):655. pmid:10649300
  19. 19. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual percent change in trend analysis. Stat Med. 2009; 28(29):3670–8. pmid:19856324
  20. 20. Oliveira AF, Valente JG, Leite IC, Schramm JM, Azevedo AS, Gadelha AM. Global burden of disease attributable to diabetes mellitus in Brazil. Cad Saude Publica. 2009;25(6):1234–44. pmid:19503954
  21. 21. Redelings MD, Sorvillo F, Simon P. A comparison of underlying cause and multiple causes of death. US Vital Statistics, 2000–2001. Epidemiology. 2006;17(1):100–3. pmid:16357601
  22. 22. World Health Organization. Global status report on noncommunicable diseases 2014. Switzerland: World Health Organization; 2014. 298 p.
  23. 23. Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Menezes PR. Doenças crônicas não transmissíveis no Brasil: carga e desafios atuais. Lancet. 2011;377(9781):1949–61.
  24. 24. Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377(9781):1778–97.
  25. 25. Macinko J, Lima-Costa MF. Horizontal equity in health care utilization in Brazil, 1998–2008. Int J Equity Health. 2012;11(1):33.
  26. 26. Nucci LB, Toscano CM, Maia ALM, Fonseca CD, Britto MMB; Brazilian National Campaign for Diabetes Mellitus Detection Working Group. A nationwide population screening program for diabetes in Brazil. Rev Panam Salud Publica. 2004;16(5):320–7. pmid:15729981
  27. 27. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise de Situação de Saúde. Plano de Ações Estratégicas para o Enfrentamento das Doenças Crônicas Não Transmissíveis (DCNT) no Brasil 2011–2022. Brasília: Ministério da Saúde; 2011. 160 p. Portuguese.
  28. 28. Evans JMM, Barnett KN, Ogston SA, Morris AD. Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality? Diabetologia. 2007;50(4):729–32. pmid:17225122
  29. 29. Charlton J, Latinovic R, Gulliford MC. Explaining the decline in early mortality in men and women with type 2 diabetes: population-based cohort study. Diabete Care. 2008;31(9):1761–6.
  30. 30. Gulliford MC, Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol. 2009;169(4):455–61. pmid:19037005
  31. 31. Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS; Scottish Diabetes Research Network Epidemiology Group. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54(12):3003–6. pmid:21959958
  32. 32. Wändell PE, Carlsson AC. Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden—A model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract. 2014;106(3):e90–2.
  33. 33. Sattar N. Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab. 2013;27(4):501–7. pmid:24054927
  34. 34. Instituto Brasileiro de Geografia e Estatística. Diretoria de Pesquisas. Coordenação de Trabalho e Rendimento. Pesquisa de Orçamentos Familiares 2008–2009. Antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2010. 130 p. Portuguese.
  35. 35. Kautzky-Willer A, Weitgasser R, Fasching P, Hoppochler F, Lechleitner M. [Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes] Wien Klin Wochenschr. 2012;124 Suppl 2:S91–6. German.
  36. 36. Bertoldi AD, Kanavos P, França GV, Carraro A, Tejada CA, Schmidt MI, et al. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health. 2013;9:62. pmid:24299125
  37. 37. Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858, 507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542–51. pmid:24859435
  38. 38. Beltrão KI, Duchiade MP. Evolução da educação formal no Brasil: ganhos passados com espaço para oportunidades futuras. In: Camarano AA. Novo regime demográfico: uma nova relação entre população e desenvolvimento? Rio de Janeiro: Instituto de Pesquisa Econômica Aplicada; 2014. p.469–90. Portuguese.
  39. 39. Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40(3):804–18. pmid:21335614
  40. 40. Demakakos P, Marmot M, Steptoe A. Socioeconomic position and the incidence of type 2 diabetes: the ELSA study. Eur J Epidemiol. 2012;27(5):367–78. pmid:22539241
  41. 41. Gary-Webb TL, Suglia SF, Tehranifar P. Social epidemiology of diabetes and associated conditions. Curr Diab Rep. 2013;13(6):850–9. pmid:24085624
  42. 42. Smith PM, Smith BT, Mustard CA, Lu H, Glazier RH. Estimating the direct and indirect pathways between education and diabetes incidence among Canadian men and women: a mediation analysis. Ann Epidemiol. 2013;23(3):143–9. pmid:23394978
  43. 43. Devaux M, Sassi F, Church J, Cecchini M, Borgonovi F. Exploring the relationship between education and obesity. OECD J Econ Stud. 2011;2011(1):1–40.
  44. 44. Kavanagh A, Bentley RJ, Turrel G, Shaw J, Dunstan D, Subramanian SV. Socioeconomic position, gender, health behaviours and biomarkers of cardiovascular disease and diabetes. Soc Sci Med. 2010;71(6):1150–60. pmid:20667641
  45. 45. Li J, Powdthavee N. Does more education lead to better health habits? Evidence from the school reforms in Australia. Soc Sci Med. 2015;127:83–91. pmid:25028347
  46. 46. American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 2015;38 Suppl:S8–16. pmid:25537714
  47. 47. Lima EEC, Queiroz BL. Evolution of the deaths registry system in Brazil: associations with changes in the mortality profile, under-registration of death counts, and ill-defined causes of death. Cad Saude Publica. 2014;30(8):1721–30. pmid:25210911
  48. 48. Cheng YJ, Imperatore G, Geiss LS, Wang J, Saydah SH, Gregg EW, et al. Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988–2010. Diabetes Care. 2013;36(9):2690–6. pmid:23637354
  49. 49. Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49(2):1–32. pmid:11381674
  50. 50. Guimaraes RM, Muzi CD, Boccolini CS, Boccolini PMM, Boeira SF. [Trends of colorectal cancer mortality in Brazil according to sex, 1980–2009] Cad Saude Colet. 2012; 20(1):121–7. Portuguese.
  51. 51. Bajekal M, Scholes S, O`Flahert M, Raine R, Norman P, Capewell S. Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982–2006: an analytical study. PLOS One. 2013;8(3): e59608. pmid:23527228